HEADER TRANSFERASE/TRANSFERASE INHIBITOR 15-JUN-17 5XSR TITLE NOVEL ORALLY EFFICACIOUS INHIBITORS COMPLEXED WITH PARP1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 660-1011; COMPND 5 SYNONYM: PARP-1,ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 1,ARTD1, COMPND 6 NAD(+) ADP-RIBOSYLTRANSFERASE 1,ADPRT 1,POLY[ADP-RIBOSE] SYNTHASE 1; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP1, ADPRT, PPOL; SOURCE 6 EXPRESSION_SYSTEM: ENTEROBACTERIA PHAGE L1; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 268588; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PGEX-6P-1 KEYWDS COMPLEX STRUCTURE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Q.LIU,Y.XU REVDAT 2 22-NOV-23 5XSR 1 REMARK REVDAT 1 25-APR-18 5XSR 0 JRNL AUTH X.CHEN,X.HUAN,Q.LIU,Y.WANG,Q.HE,C.TAN,Y.CHEN,J.DING,Y.XU, JRNL AUTH 2 Z.MIAO,C.YANG JRNL TITL DESIGN AND SYNTHESIS OF JRNL TITL 2 2-(4,5,6,7-TETRAHYDROTHIENOPYRIDIN-2-YL)-BENZOIMIDAZOLE JRNL TITL 3 CARBOXAMIDES AS NOVEL ORALLY EFFICACIOUS JRNL TITL 4 POLY(ADP-RIBOSE)POLYMERASE (PARP) INHIBITORS JRNL REF EUR J MED CHEM V. 145 389 2018 JRNL REFN ISSN 1768-3254 JRNL PMID 29335205 JRNL DOI 10.1016/J.EJMECH.2018.01.018 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.250 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 49568 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.980 REMARK 3 FREE R VALUE TEST SET COUNT : 1477 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.0498 - 5.1130 1.00 4388 136 0.2028 0.2033 REMARK 3 2 5.1130 - 4.0591 1.00 4361 137 0.1582 0.1595 REMARK 3 3 4.0591 - 3.5462 1.00 4381 126 0.1920 0.2433 REMARK 3 4 3.5462 - 3.2220 1.00 4364 140 0.2166 0.2246 REMARK 3 5 3.2220 - 2.9911 1.00 4393 137 0.2397 0.3116 REMARK 3 6 2.9911 - 2.8148 1.00 4368 134 0.2535 0.2762 REMARK 3 7 2.8148 - 2.6738 1.00 4349 130 0.2582 0.2922 REMARK 3 8 2.6738 - 2.5575 1.00 4401 137 0.2715 0.3447 REMARK 3 9 2.5575 - 2.4590 1.00 4367 132 0.2689 0.2905 REMARK 3 10 2.4590 - 2.3742 1.00 4364 131 0.2629 0.3166 REMARK 3 11 2.3742 - 2.2999 1.00 4355 137 0.2671 0.2924 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.450 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.01 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2637 REMARK 3 ANGLE : 0.906 3582 REMARK 3 CHIRALITY : 0.053 411 REMARK 3 PLANARITY : 0.006 456 REMARK 3 DIHEDRAL : 6.022 1584 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5XSR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 20-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1300004114. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9791 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49570 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 47.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.49 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 11.58 REMARK 200 R MERGE FOR SHELL (I) : 0.87900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.270 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4HHY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 80MM NACL, 1.9M (NH4)2SO4, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+1/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 150.28000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 75.14000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 112.71000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 37.57000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 187.85000 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 150.28000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 75.14000 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 37.57000 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 112.71000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 187.85000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 ASP A 122 REMARK 465 ASP A 123 REMARK 465 THR A 163 REMARK 465 THR A 164 REMARK 465 HIS A 165 REMARK 465 ASN A 166 REMARK 465 THR A 350 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 3 CG CD CE NZ REMARK 470 LYS A 23 CE NZ REMARK 470 GLU A 27 OE1 OE2 REMARK 470 LYS A 39 CE NZ REMARK 470 SER A 41 OG REMARK 470 LYS A 42 CG CD CE NZ REMARK 470 ARG A 43 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 44 OE1 NE2 REMARK 470 ILE A 45 CD1 REMARK 470 ILE A 51 CD1 REMARK 470 GLN A 57 CG CD OE1 NE2 REMARK 470 SER A 66 OG REMARK 470 GLN A 67 CG CD OE1 NE2 REMARK 470 ILE A 68 CD1 REMARK 470 LEU A 69 CG CD1 CD2 REMARK 470 ASP A 70 CG OD1 OD2 REMARK 470 ARG A 74 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 86 CG CD CE NZ REMARK 470 LYS A 87 CG CD CE NZ REMARK 470 ARG A 118 CG CD NE CZ NH1 NH2 REMARK 470 SER A 121 OG REMARK 470 SER A 124 OG REMARK 470 SER A 125 OG REMARK 470 LYS A 126 CG CD CE NZ REMARK 470 LYS A 141 CE NZ REMARK 470 ASP A 144 OD1 OD2 REMARK 470 LYS A 155 CE NZ REMARK 470 LYS A 158 CE NZ REMARK 470 HIS A 161 CG ND1 CD2 CE1 NE2 REMARK 470 ASP A 169 CG OD1 OD2 REMARK 470 LYS A 177 CE NZ REMARK 470 GLU A 179 OE1 OE2 REMARK 470 LYS A 188 CG CD CE NZ REMARK 470 LYS A 191 CD CE NZ REMARK 470 GLN A 192 CG CD OE1 NE2 REMARK 470 HIS A 194 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 217 NE CZ NH1 NH2 REMARK 470 SER A 250 OG REMARK 470 ASP A 253 OD1 OD2 REMARK 470 ASN A 267 OD1 ND2 REMARK 470 LYS A 272 NZ REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 LYS A 292 CD CE NZ REMARK 470 VAL A 318 CG1 CG2 REMARK 470 ASN A 319 CG OD1 ND2 REMARK 470 ASP A 320 CG OD1 OD2 REMARK 470 THR A 321 OG1 CG2 REMARK 470 SER A 322 OG REMARK 470 LEU A 324 CG CD1 CD2 REMARK 470 LYS A 349 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 64 O HOH A 501 1.98 REMARK 500 O HOH A 617 O HOH A 623 2.09 REMARK 500 OE2 GLU A 29 O HOH A 502 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 29 36.12 70.79 REMARK 500 ASN A 92 18.85 -143.37 REMARK 500 ASP A 146 43.44 -100.13 REMARK 500 PRO A 254 35.38 -83.86 REMARK 500 ASN A 319 -81.62 -60.85 REMARK 500 ASP A 320 77.78 -102.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 8EC A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 DBREF 5XSR A 1 350 UNP P09874 PARP1_HUMAN 662 1011 SEQADV 5XSR GLY A -4 UNP P09874 EXPRESSION TAG SEQADV 5XSR PRO A -3 UNP P09874 EXPRESSION TAG SEQADV 5XSR LEU A -2 UNP P09874 EXPRESSION TAG SEQADV 5XSR GLY A -1 UNP P09874 EXPRESSION TAG SEQADV 5XSR SER A 0 UNP P09874 EXPRESSION TAG SEQADV 5XSR ALA A 101 UNP P09874 VAL 762 VARIANT SEQRES 1 A 355 GLY PRO LEU GLY SER LYS SER LYS LEU PRO LYS PRO VAL SEQRES 2 A 355 GLN ASP LEU ILE LYS MET ILE PHE ASP VAL GLU SER MET SEQRES 3 A 355 LYS LYS ALA MET VAL GLU TYR GLU ILE ASP LEU GLN LYS SEQRES 4 A 355 MET PRO LEU GLY LYS LEU SER LYS ARG GLN ILE GLN ALA SEQRES 5 A 355 ALA TYR SER ILE LEU SER GLU VAL GLN GLN ALA VAL SER SEQRES 6 A 355 GLN GLY SER SER ASP SER GLN ILE LEU ASP LEU SER ASN SEQRES 7 A 355 ARG PHE TYR THR LEU ILE PRO HIS ASP PHE GLY MET LYS SEQRES 8 A 355 LYS PRO PRO LEU LEU ASN ASN ALA ASP SER VAL GLN ALA SEQRES 9 A 355 LYS ALA GLU MET LEU ASP ASN LEU LEU ASP ILE GLU VAL SEQRES 10 A 355 ALA TYR SER LEU LEU ARG GLY GLY SER ASP ASP SER SER SEQRES 11 A 355 LYS ASP PRO ILE ASP VAL ASN TYR GLU LYS LEU LYS THR SEQRES 12 A 355 ASP ILE LYS VAL VAL ASP ARG ASP SER GLU GLU ALA GLU SEQRES 13 A 355 ILE ILE ARG LYS TYR VAL LYS ASN THR HIS ALA THR THR SEQRES 14 A 355 HIS ASN ALA TYR ASP LEU GLU VAL ILE ASP ILE PHE LYS SEQRES 15 A 355 ILE GLU ARG GLU GLY GLU CYS GLN ARG TYR LYS PRO PHE SEQRES 16 A 355 LYS GLN LEU HIS ASN ARG ARG LEU LEU TRP HIS GLY SER SEQRES 17 A 355 ARG THR THR ASN PHE ALA GLY ILE LEU SER GLN GLY LEU SEQRES 18 A 355 ARG ILE ALA PRO PRO GLU ALA PRO VAL THR GLY TYR MET SEQRES 19 A 355 PHE GLY LYS GLY ILE TYR PHE ALA ASP MET VAL SER LYS SEQRES 20 A 355 SER ALA ASN TYR CYS HIS THR SER GLN GLY ASP PRO ILE SEQRES 21 A 355 GLY LEU ILE LEU LEU GLY GLU VAL ALA LEU GLY ASN MET SEQRES 22 A 355 TYR GLU LEU LYS HIS ALA SER HIS ILE SER LYS LEU PRO SEQRES 23 A 355 LYS GLY LYS HIS SER VAL LYS GLY LEU GLY LYS THR THR SEQRES 24 A 355 PRO ASP PRO SER ALA ASN ILE SER LEU ASP GLY VAL ASP SEQRES 25 A 355 VAL PRO LEU GLY THR GLY ILE SER SER GLY VAL ASN ASP SEQRES 26 A 355 THR SER LEU LEU TYR ASN GLU TYR ILE VAL TYR ASP ILE SEQRES 27 A 355 ALA GLN VAL ASN LEU LYS TYR LEU LEU LYS LEU LYS PHE SEQRES 28 A 355 ASN PHE LYS THR HET 8EC A 401 22 HET SO4 A 403 5 HET SO4 A 404 5 HETNAM 8EC 6-FLUORANYL-2-(4,5,6,7-TETRAHYDROTHIENO[2,3-C]PYRIDIN- HETNAM 2 8EC 2-YL)-1~{H}-BENZIMIDAZOLE-4-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 2 8EC C15 H13 F N4 O S FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 HOH *155(H2 O) HELIX 1 AA1 PRO A 5 PHE A 16 1 12 HELIX 2 AA2 ASP A 17 TYR A 28 1 12 HELIX 3 AA3 PRO A 36 LEU A 40 5 5 HELIX 4 AA4 SER A 41 GLY A 62 1 22 HELIX 5 AA5 SER A 64 ILE A 79 1 16 HELIX 6 AA6 ASN A 93 GLY A 119 1 27 HELIX 7 AA7 ASP A 127 LYS A 135 1 9 HELIX 8 AA8 SER A 147 THR A 160 1 14 HELIX 9 AA9 GLY A 182 LYS A 188 1 7 HELIX 10 AB1 PRO A 189 LEU A 193 5 5 HELIX 11 AB2 ARG A 204 THR A 206 5 3 HELIX 12 AB3 ASN A 207 GLY A 215 1 9 HELIX 13 AB4 MET A 239 ASN A 245 1 7 HELIX 14 AB5 TYR A 246 HIS A 248 5 3 HELIX 15 AB6 PRO A 297 ASN A 300 5 4 HELIX 16 AB7 ASP A 332 ALA A 334 5 3 SHEET 1 AA1 5 THR A 138 VAL A 142 0 SHEET 2 AA1 5 TYR A 168 ARG A 180 -1 O LYS A 177 N LYS A 141 SHEET 3 AA1 5 VAL A 336 PHE A 348 -1 O ASN A 347 N ASP A 169 SHEET 4 AA1 5 ILE A 255 ALA A 264 -1 N GLY A 256 O LEU A 344 SHEET 5 AA1 5 ARG A 196 GLY A 202 -1 N LEU A 199 O GLY A 261 SHEET 1 AA2 4 ILE A 234 PHE A 236 0 SHEET 2 AA2 4 GLU A 327 VAL A 330 -1 O TYR A 328 N PHE A 236 SHEET 3 AA2 4 SER A 286 GLY A 289 -1 N GLY A 289 O GLU A 327 SHEET 4 AA2 4 MET A 268 LEU A 271 1 N TYR A 269 O SER A 286 SHEET 1 AA3 3 GLY A 313 SER A 315 0 SHEET 2 AA3 3 GLY A 291 PRO A 295 -1 N THR A 294 O ILE A 314 SHEET 3 AA3 3 LEU A 323 TYR A 325 1 O LEU A 324 N THR A 293 SHEET 1 AA4 2 ILE A 301 LEU A 303 0 SHEET 2 AA4 2 VAL A 306 VAL A 308 -1 O VAL A 308 N ILE A 301 SSBOND 1 CYS A 184 CYS A 184 1555 8555 2.07 SITE 1 AC1 13 GLU A 102 ASP A 105 HIS A 201 GLY A 202 SITE 2 AC1 13 TYR A 228 TYR A 235 PHE A 236 ALA A 237 SITE 3 AC1 13 LYS A 242 SER A 243 TYR A 246 GLU A 327 SITE 4 AC1 13 HOH A 547 SITE 1 AC2 3 GLY A 182 CYS A 184 GLN A 185 SITE 1 AC3 6 ARG A 204 THR A 205 THR A 206 HOH A 512 SITE 2 AC3 6 HOH A 515 HOH A 550 SITE 1 AC4 3 LYS A 242 LEU A 324 TYR A 325 CRYST1 94.080 94.080 225.420 90.00 90.00 120.00 P 65 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010629 0.006137 0.000000 0.00000 SCALE2 0.000000 0.012274 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004436 0.00000